News and Media
Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth
CANTON, Mich. (2/7/2023) – MMS Holdings (MMS) – an award-winning, data-focused contract research organization (CRO) – announces the expansion of its leadership team with the appointment of Chris Schoonmaker as Chief Operating Officer and Ashu Tandon as Chief...
MMS Named a Great Place to Work in India
BANGALORE, India (1/12/2023) – MMS Holdings, a data-focused contract research organization (CRO), has been named a Great Place to Work by the Great Place to Work Institute of India. This award is based on anonymous feedback from a survey sent out to employees and...
MMS Named Michigan Top Workplace For The Second Consecutive Year
CANTON, Mich. (11/21/2022) – MMS Holdings, a data-focused contract research organization (CRO), has been named a 2022 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. This is the second year that MMS has been recognized with this...
MMS Announces Key Executive Appointment to Support Company’s Next Stage of Growth
CANTON, Mich. (8/30/2022) – MMS Holdings Inc. (MMS) – a leading contract research organization (CRO) – announced the appointment of Kelly J. Hill to Chief Strategy Officer. This appointment reflects the company’s accelerating growth as it continues to deliver...
Together Trial with EDC Database Designed by MMS Wins Trial of the Year
CANTON, Mich. (8/16/2022) – The TOGETHER Trial, which uses an Electronic Data Capture (EDC) system designed, built, and maintained by MMS Holdings, a data-focused contract research organization (CRO), won the Society for Clinical Trial’s annual Trial of the Year Award...
MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth
The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS’ leadership in data-focused clinical research services. CANTON, Michigan – June 28, 2022 – MMS Holdings Inc. (“MMS” or the “Company”), a leading data-focused...
Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings
On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted...
MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors
CANTON, MI (6/7/2022) – MMS Holdings, a data-focused Contract Research Organization (CRO), is pleased to announce a strategic partnership with Medidata, a Dassault Systèmes company, to provide clients a full range of solutions for clinical data management (CDM) and...
MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials
CANTON, Mich. (05/24/2022) – MMS Holdings Inc. (MMS) – an award-winning, data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services....
SUBSCRIBE TO UPDATES
Please provide your information to stay informed.
Avery Zimmerman
6880 Commerce Blvd.
Canton, MI 48187 USA
734 245 0310
media@mmsholdings.com
CONNECT WITH US